CRISPR & Cas Genes Market by Component, Application, End-user - Global Forecast 2025-2030- Product Image

Sale

CRISPR & Cas Genes Market by Component, Application, End-user - Global Forecast 2025-2030

Report
197 Pages
October 2024
Region: Global
360iResearch™
ID: 6011578

UP TO €681EUR$697USD£569GBP OFF until Dec 31^st 2024

The CRISPR & Cas Genes Market grew from USD 3.81 billion in 2023 to USD 5.04 billion in 2024. It is expected to continue growing at a CAGR of 32.40%, reaching USD 27.21 billion by 2030.

CRISPR & Cas Genes represent a groundbreaking area within genetic research, functioning as a precise tool for genome editing that allows scientists to modify DNA sequences with high accuracy and efficiency. The necessity of CRISPR-Cas systems arises from their potential to revolutionize fields such as biotechnology, medicine, and agriculture by enabling applications like gene therapy for genetic disorders, enhancement of agricultural crops, and development of innovative treatments for diseases. The end-use scope spans industries including pharmaceuticals, biotechnology companies, research institutions, and agricultural sectors which are rapidly integrating these technologies to enhance product offerings and research capabilities. Key growth drivers in the CRISPR-Cas market include advancements in genome editing technology, increasing investments in biotechnological research and development, and rising demand for novel therapeutic solutions. The regulatory landscape is also evolving to facilitate the adoption of gene-editing technologies, although ethical concerns and legal challenges pose limitations. Significant market opportunities lie in developing CRISPR-based diagnostic tools, therapies for rare and hereditary diseases, and sustainable agricultural solutions. Companies can capitalize on these opportunities through strategic partnerships and investing in cutting-edge research that aligns with regulatory standards. However, challenges such as off-target effects, delivery mechanisms for CRISPR components, and intellectual property disputes could impede growth. Continuous innovation in delivery vectors and improvements in specificity and safety are pivotal areas for research to address these challenges. Moreover, an emphasis on ethical practices and transparent regulatory compliance will be essential to gain public trust and facilitate market penetration. The CRISPR & Cas Genes market is characterized by rapid technological advancements and a dynamic competitive landscape, necessitating a keen focus on research, collaborations, and strategic adaptability for sustained business growth.

Understanding Market Dynamics in the CRISPR & Cas Genes Market

The CRISPR & Cas Genes Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Development of CRISPR-based diagnostic assays for sample tissue screening
- High prevalence of genetic disorders
- Rising application in drug discovery, biomedical research, and non-transgenic bleeding
Market Restraints
- Off-target effects of CRISPR technology
Market Opportunities
- Evolution of anti-CRISPR protein
- Research and development for novel application of CRISPR-Cas genes
Market Challenges
- Patent landscape and dispute

Exploring Porter’s Five Forces for the CRISPR & Cas Genes Market

Porter’s Five Forces framework further strengthens the insights of the CRISPR & Cas Genes Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the CRISPR & Cas Genes Market

External macro-environmental factors deeply influence the performance of the CRISPR & Cas Genes Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the CRISPR & Cas Genes Market

The CRISPR & Cas Genes Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the CRISPR & Cas Genes Market

The CRISPR & Cas Genes Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the CRISPR & Cas Genes Market

The CRISPR & Cas Genes Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the CRISPR & Cas Genes Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca plc, Beam Therapeutics Inc., Beckman Coulter, Inc., Calyxt, Inc., Caribou Biosciences, Inc., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., Hera Biolabs, Horizon Discovery Group Plc, Inscripta, Inc., Integrated Dna Technologies, Inc., Intellia Therapeutics, Inc., Lonza Group, and Mammoth Biosciences.

Market Segmentation & Coverage

This research report categorizes the CRISPR & Cas Genes Market to forecast the revenues and analyze trends in each of the following sub-markets:

Component
- Product
  - Antibodies
  - Design Tool
  - Kits & Enzymes
    - DNA-Free Cas
    - Vector-Based Cas
  - Libraries
- Service
  - Cell Line Engineering
  - DNA Synthesis
  - gRNA Design
  - Microbial Gene Editing
Application
- Agricultural
- Biomedical
  - Disease Model Studies
  - Epigenetics
  - Functional Genomics
  - Genome Engineering
End-user
- Academics & Government Research Institutes
- Biotechnology & Pharmaceutical Companies
- Contract Research Organizations

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Development of CRISPR-based diagnostic assays for sample tissue screening
5.1.1.2. High prevalence of genetic disorders
5.1.1.3. Rising application in drug discovery, biomedical research, and non-transgenic bleeding
5.1.2. Restraints
5.1.2.1. Off-target effects of CRISPR technology
5.1.3. Opportunities
5.1.3.1. Evolution of anti-CRISPR protein
5.1.3.2. Research and development for novel application of CRISPR-Cas genes
5.1.4. Challenges
5.1.4.1. Patent landscape and dispute
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. CRISPR & Cas Genes Market, by Component

6.1. Introduction
6.2. Product
6.2.1. Antibodies
6.2.2. Design Tool
6.2.3. Kits & Enzymes
6.2.3.1. DNA-Free Cas
6.2.3.2. Vector-Based Cas
6.2.4. Libraries
6.3. Service
6.3.1. Cell Line Engineering
6.3.2. DNA Synthesis
6.3.3. gRNA Design
6.3.4. Microbial Gene Editing

7. CRISPR & Cas Genes Market, by Application

7.1. Introduction
7.2. Agricultural
7.3. Biomedical
7.3.1. Disease Model Studies
7.3.2. Epigenetics
7.3.3. Functional Genomics
7.3.4. Genome Engineering

8. CRISPR & Cas Genes Market, by End-user

8.1. Introduction
8.2. Academics & Government Research Institutes
8.3. Biotechnology & Pharmaceutical Companies
8.4. Contract Research Organizations

9. Americas CRISPR & Cas Genes Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific CRISPR & Cas Genes Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa CRISPR & Cas Genes Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation

LIST OF FIGURES

FIGURE 1. CRISPR & CAS GENES MARKET RESEARCH PROCESS
FIGURE 2. CRISPR & CAS GENES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. CRISPR & CAS GENES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. CRISPR & CAS GENES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

TABLE 1. CRISPR & CAS GENES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. CRISPR & CAS GENES MARKET DYNAMICS
TABLE 7. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DESIGN TOOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DNA-FREE CAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY VECTOR-BASED CAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY LIBRARIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GRNA DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY MICROBIAL GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY DISEASE MODEL STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY EPIGENETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY GENOME ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CANADA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 58. CANADA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 59. CANADA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 60. CANADA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 61. CANADA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 63. CANADA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 70. MEXICO CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. CHINA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 95. CHINA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 96. CHINA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 97. CHINA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 98. CHINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. CHINA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 100. CHINA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. INDIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 102. INDIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. INDIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 104. INDIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 105. INDIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. INDIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 107. INDIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. JAPAN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 116. JAPAN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 117. JAPAN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 118. JAPAN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 119. JAPAN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. JAPAN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 121. JAPAN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. THAILAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 158. THAILAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. THAILAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 160. THAILAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 161. THAILAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. THAILAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 163. THAILAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 179. DENMARK CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 180. DENMARK CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. DENMARK CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 182. DENMARK CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 183. DENMARK CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. DENMARK CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 185. DENMARK CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. EGYPT CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 187. EGYPT CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 188. EGYPT CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 189. EGYPT CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 190. EGYPT CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. EGYPT CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 192. EGYPT CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. FINLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 199. FINLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. FRANCE CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 201. FRANCE CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 202. FRANCE CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 203. FRANCE CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 204. FRANCE CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. FRANCE CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 206. FRANCE CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. GERMANY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 208. GERMANY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. GERMANY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 210. GERMANY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 211. GERMANY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. GERMANY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 213. GERMANY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. ITALY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 222. ITALY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 223. ITALY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 224. ITALY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 225. ITALY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. ITALY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 227. ITALY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 246. NORWAY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 248. NORWAY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. POLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 250. POLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 251. POLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 252. POLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 253. POLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 255. POLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. QATAR CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 257. QATAR CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. QATAR CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 259. QATAR CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 260. QATAR CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. QATAR CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 262. QATAR CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 284. SPAIN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 285. SPAIN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 286. SPAIN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 287. SPAIN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 288. SPAIN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. SPAIN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 290. SPAIN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 305. TURKEY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 306. TURKEY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 307. TURKEY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 308. TURKEY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 309. TURKEY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. TURKEY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 311. TURKEY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 326. CRISPR & CAS GENES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 327. CRISPR & CAS GENES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the CRISPR & Cas Genes market, which are profiled in this report, include:

AstraZeneca plc
Beam Therapeutics Inc.
Beckman Coulter, Inc.
Calyxt, Inc.
Caribou Biosciences, Inc.
CRISPR Therapeutics AG
Danaher Corporation
Editas Medicine, Inc.
Hera Biolabs
Horizon Discovery Group Plc
Inscripta, Inc.
Integrated Dna Technologies, Inc.
Intellia Therapeutics, Inc.
Lonza Group
Mammoth Biosciences

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	197
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.04 Billion
Forecasted Market Value ( USD ) by 2030	$ 27.21 Billion
Compound Annual Growth Rate	32.4%
Regions Covered	Global
No. of Companies Mentioned	16

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3466EUR$3,545USD£2,895GBP €3851EUR$3,939USD£3,217GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6132EUR$6,272USD£5,122GBP €6813EUR$6,969USD£5,691GBP

Understanding Market Dynamics in the CRISPR & Cas Genes Market

Exploring Porter’s Five Forces for the CRISPR & Cas Genes Market

Applying PESTLE Analysis to the CRISPR & Cas Genes Market

Analyzing Market Share in the CRISPR & Cas Genes Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the CRISPR & Cas Genes Market

Strategic Recommendations for Success in the CRISPR & Cas Genes Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

CRISPR Gene Editing Market by Offering, Technology, Application, End-use - Global Forecast 2025-2030

CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030

CRISPR and Cas Gene Global Market Report 2024

CRISPR Technology - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Global CRISPR Gene Editing Market Report 2024